From: Splicing isoform-specific functional genomic in cancer cells
Gene | ASE type | Backbone chemistry | Relative location | Splicing effect | Phenotype | Ref. |
---|---|---|---|---|---|---|
MDM2 | cassette | PNA | Spanning the 3’ss intron-exon junction | Promote intron retention and exon exclusion | Sensitize JAR cells to camptothecin | [81] |
PRKCD | Alt5’ | 2’-MOE-PS | Covering the proximal 5’ss | Promote usage of the distal 5’ss | Induce apoptosis in NT2 cells | [68] |
FLT1 (VEGFR1) | cassette | morpholino | Spanning 5’ss exon-intron junction | Induce exon exclusion | Suppress laser-induced choroidal neovascularization | [82] |
KDR (VEGFR2) | cassette | morpholino | Spanning 5’ss exon-intron junction | Induce exon exclusion | Suppress laser-induced choroidal neovascularization | [83] |
MCL1 | cassette | morpholino | Spanning 3’ss intron-exon junction | Induce exon exclusion | Induce apoptosis in BCC and AGS cells | [84] |
morpholino | Spanning 5’ss exon-intron junction | Induce exon exclusion | Induce apoptosis in BCC and AGS cells | [84] | ||
VEGF | cassette | morpholino | Spanning 3’ss intron-exon junction | Induce exon exclusion | Induce angiogenesis in PC-3 | [85] |
TAF6 | Alt5’ | PS-2’OMe | Fully exonic between both 5;ss | Promote the proximal 5’ss | Induce apoptosis in HeLa cells | [86] |
SYK | cassette | 2’OMe | Fully exonic | Induce exon exclusion | Induce apoptosis in SKOV3ip1 | [43] |
ATR | cassette | PS-2’OMe | Fully exonic | Induce exon exclusion | Induce apoptosis of Eu-myc B cells | [58] |
EP400 | cassette | PS-2’OMe | Fully exonic | Induce exon exclusion | Induce apoptosis of Eu-myc B cells | [58] |
DVL1 | Intron retention | PS-2’OMe | 2 oligonucleotides One Spanning 5’ss exon-intron junction One Spanning 3’ss intron-exon junction | Promote intron retention | Induce apoptosis of Eu-myc B cells | [58] |
ERBB4 | cassette | LNA, 2’OMe | Fully exonic | Induce exon exclusion | Inhibit growth in MCF7 and T47D | [87] |
PKM | Mutually exclusive two exon cassette | PS-2’MOE | Fully exonic | Induce concommittant exon 9 inclusion and exon 10 exclusion | Induce apoptosis in U87-MG and A172 cells | [88] |
STAT3 | Alt3’ | morpholino | Spanning 3’ss intron-exon junction | Promote distal 3’ss | Induce cell death in MDA-MB-435 and MBA-MB-468 | [89] |
MDM4 | cassette | morpholino | Spanning 5’ss exon-intron junction | Induce exon exclusion | Inhibit cell growth in melanoma cell lines | [90] |
GLDC | cassette | PS 2’OMe | Fully exonic | Induce exon exclusion | Inhibit cell growth of A549 cells | [91] |
USP5 | Alt5’ | morpholino | Covering the proximal 5’ss | Promote usage of the distal 5’ss | Inhibit cell growth and migration in U251 and LN229 | [92] |
BRCA1 | cassette | morpholino | Fully exonic | Induce exon exclusion | Inhibit cell growth in combination with PARP inhibitor in MCF-7 and MDA-MB-231 | [93] |
MKNK2 | Alt3’ | PS-2’MOE and PS-2’OMe | Spanning distal 3’ss junction | Promote proximal 3’ss | Sensitize cells to chemotherapy | [94] |
BIM | cassette | PS-2’MOE | Fully exonic | Induce exon exclusion | Restored imatinib-induced apoptosis in KCL22 cells | [95] |